159 related articles for article (PubMed ID: 16495279)
1. Roles of cellular respiration, CgCDR1, and CgCDR2 in Candida glabrata resistance to histatin 5.
Helmerhorst EJ; Venuleo C; Sanglard D; Oppenheim FG
Antimicrob Agents Chemother; 2006 Mar; 50(3):1100-3. PubMed ID: 16495279
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
[TBL] [Abstract][Full Text] [Related]
3. Candida glabrata is unusual with respect to its resistance to cationic antifungal proteins.
Helmerhorst EJ; Venuleo C; Beri A; Oppenheim FG
Yeast; 2005 Jul; 22(9):705-14. PubMed ID: 16034806
[TBL] [Abstract][Full Text] [Related]
4. Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrata.
Ferrari S; Sanguinetti M; Torelli R; Posteraro B; Sanglard D
PLoS One; 2011 Mar; 6(3):e17589. PubMed ID: 21408004
[TBL] [Abstract][Full Text] [Related]
5. Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata.
Gohar AA; Badali H; Shokohi T; Nabili M; Amirrajab N; Moazeni M
Mycopathologia; 2017 Apr; 182(3-4):273-284. PubMed ID: 27744635
[TBL] [Abstract][Full Text] [Related]
6. Azole resistance of Candida glabrata in a case of recurrent fungemia.
Posteraro B; Tumbarello M; La Sorda M; Spanu T; Trecarichi EM; De Bernardis F; Scoppettuolo G; Sanguinetti M; Fadda G
J Clin Microbiol; 2006 Aug; 44(8):3046-7. PubMed ID: 16891541
[TBL] [Abstract][Full Text] [Related]
7. Expression of Efflux Pumps and Fatty Acid Activator One Genes in Azole Resistant Candida Glabrata Isolated From Immunocompromised Patients.
Farahyar S; Zaini F; Kordbacheh P; Rezaie S; Falahati M; Safara M; Raoofian R; Hatami K; Mohebbi M; Heidari M
Acta Med Iran; 2016 Jul; 54(7):458-64. PubMed ID: 27424018
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Efflux Pump Activity in Old Candida glabrata Cells.
Bhattacharya S; Fries BC
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311061
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
[TBL] [Abstract][Full Text] [Related]
10. Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes.
Posteraro B; Sanguinetti M; Fiori B; La Sorda M; Spanu T; Sanglard D; Fadda G
J Antimicrob Chemother; 2006 Aug; 58(2):458-61. PubMed ID: 16757500
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin selects for fluconazole-resistant petite mutants in Candida glabrata isolates.
Schulz B; Knobloch M; Weber K; Ruhnke M
Int J Med Microbiol; 2012 Jul; 302(3):155-61. PubMed ID: 22664377
[TBL] [Abstract][Full Text] [Related]
12. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the CgPDR1 and CgERG11 genes in azole-resistant Candida glabrata clinical isolates from Slovakia.
Berila N; Borecka S; Dzugasova V; Bojnansky J; Subik J
Int J Antimicrob Agents; 2009 Jun; 33(6):574-8. PubMed ID: 19196495
[TBL] [Abstract][Full Text] [Related]
14. Histatin 5 resistance of Candida glabrata can be reversed by insertion of Candida albicans polyamine transporter-encoding genes DUR3 and DUR31.
Tati S; Jang WS; Li R; Kumar R; Puri S; Edgerton M
PLoS One; 2013; 8(4):e61480. PubMed ID: 23613860
[TBL] [Abstract][Full Text] [Related]
15. Lipid core nanoparticles as a broad strategy to reverse fluconazole resistance in multiple Candida species.
Domingues Bianchin M; Borowicz SM; da Rosa Monte Machado G; Pippi B; Stanisçuaski Guterres S; Raffin Pohlmann A; Meneghello Fuentefria A; Clemes Külkamp-Guerreiro I
Colloids Surf B Biointerfaces; 2019 Mar; 175():523-529. PubMed ID: 30579053
[TBL] [Abstract][Full Text] [Related]
16. [Molecular mechanisms of fluconazole resistance in clinical isolates of Candida glabrata].
Shen YZ; Lu HZ; Zhang YX
Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):245-9. PubMed ID: 20450660
[TBL] [Abstract][Full Text] [Related]
17. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata.
Sanglard D; Ischer F; Bille J
Antimicrob Agents Chemother; 2001 Apr; 45(4):1174-83. PubMed ID: 11257032
[TBL] [Abstract][Full Text] [Related]
18. Statin resistance in Candida glabrata.
Subhan M; Faryal R; Macreadie I
Biotechnol Lett; 2018 Oct; 40(9-10):1389-1394. PubMed ID: 30054755
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting fungal multidrug resistance by disrupting an activator-Mediator interaction.
Nishikawa JL; Boeszoermenyi A; Vale-Silva LA; Torelli R; Posteraro B; Sohn YJ; Ji F; Gelev V; Sanglard D; Sanguinetti M; Sadreyev RI; Mukherjee G; Bhyravabhotla J; Buhrlage SJ; Gray NS; Wagner G; Näär AM; Arthanari H
Nature; 2016 Feb; 530(7591):485-9. PubMed ID: 26886795
[TBL] [Abstract][Full Text] [Related]
20. Changes in genotype and fluconazole susceptibility of isolates from patients with Candida glabrata in Tunisia.
Abbes S; Amouri I; Sellami H; Neji S; Trabelsi H; Cheikhrouhou F; Makni F; Ranque S; Ayadi A
Therapie; 2014; 69(5):449-55. PubMed ID: 25285365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]